Probing Cancer Metastasis at a Single-Cell Level with a Raman-Functionalized Anionic Probe
Source abstract
Abstract
Cancer metastasis is the primary reason for cancer-related deaths, yet there is no technique capable of detecting it due to cancer pathogenesis. Current cancer diagnosis methods evaluate tumor samples as a whole/pooled sample process loses heterogeneous information in the metastasis state. Hence, it is not suitable for metastatic cancer detection. In order to gain complete information on metastasis, it is desirable to develop a nondestructive detection method that can evaluate metastatic cells with sensitivity down to single-cell resolution. Here we demonstrated self-functionalized anionic quantum probes for in vitro metastatic cancer detection at a single-cell concentration. We achieved this by incorporating a nondestructive SERS ability within the generated probes by integrating anionic surface species and NIR plasmon resonance. To the best of our knowledge, this was the first time that metastatic cancer cells were detected through their neoplastic transformations. With reliable diagnostic information at the single-cell sensitivity in an in vitro state, we successfully discriminated against cancer malignancy states.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Gold and Silver Nanoparticles Synthesis and Applications · Advanced biosensing and bioanalysis techniques · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute for Biomedical Engineering, Science and Technology (I-BEST), Partnership between Ryerson University and St. Michael’s Hospital, Toronto, Ontario M5B 1W8, Canada
Affiliate Scientist, Keenan Research Center, St. Michael’s Hospital, 209 Victoria Street, Toronto, Ontario M5B 1T8, Canada
Funding
Natural Sciences and Engineering Research Council of Canada
References (67)
Show source-provided references
1. 10.1146/annurev.pathmechdis.3.121806.15152310.1146/annurev.pathmechdis.3.121806.151523 ↗
2. Breast Cancer: Statistics. https://www.cancer.net/cancer-types/breast-cancer/statistics, 2019.
3. Pancreatic Cancer: Statistics. https://www.cancer.net/cancer-types/pancreatic-cancer/statistics, 2018.
4. Lung Cancer - Small Cell: Statistics. https://www.cancer.net/cancer-types/lung-cancer-small-cell/statistics, 2019, pp 1–2.
5. 10.1101/gad.277681.11610.1101/gad.277681.116 ↗
6. 10.1186/1476-4598-10-2210.1186/1476-4598-10-22 ↗
7. 10.1016/bs.acr.2016.07.00110.1016/bs.acr.2016.07.001 ↗
8. 10.1038/s41591-019-0447-x10.1038/s41591-019-0447-x ↗
9. 10.1634/theoncologist.9-6-63310.1634/theoncologist.9-6-633 ↗
10. 10.1016/j.ejrad.2018.11.03410.1016/j.ejrad.2018.11.034 ↗
11. 10.1021/acs.chemrev.5b0032110.1021/acs.chemrev.5b00321 ↗
12. 10.1021/nn101133610.1021/nn1011336 ↗
13. 10.1039/c0an00204f10.1039/c0an00204f ↗
14. 10.1073/pnas.071057510510.1073/pnas.0710575105 ↗
15. 10.1021/acs.chemrev.5b0026510.1021/acs.chemrev.5b00265 ↗
16. 10.1038/natrevmats.2016.2110.1038/natrevmats.2016.21 ↗
17. 10.1021/ja910269810.1021/ja9102698 ↗
18. 10.1002/adma.20070185310.1002/adma.200701853 ↗
19. 10.1021/nn202777510.1021/nn2027775 ↗
20. 10.1021/tx200513t10.1021/tx200513t ↗
21. 10.1007/s12274-014-0697-310.1007/s12274-014-0697-3 ↗
22. Riaz N. · Drug Discov Today · 2015 · 20 · 59510.1016/j.drudis.2014.11.014 ↗
23. 10.1038/ncomms556810.1038/ncomms5568 ↗
24. 10.1002/advs.20160028010.1002/advs.201600280 ↗
25. 10.1039/C4AN01899K10.1039/C4AN01899K ↗
26. 10.1016/j.biomaterials.2007.07.02910.1016/j.biomaterials.2007.07.029 ↗
27. 10.1002/smll.20090115810.1002/smll.200901158 ↗
28. 10.1186/s13046-015-0214-x10.1186/s13046-015-0214-x ↗
29. 10.2147/IJN.S9454310.2147/IJN.S94543 ↗
30. 10.1038/nnano.2007.39710.1038/nnano.2007.397 ↗
31. 10.1038/nnano.2007.38810.1038/nnano.2007.388 ↗
32. 10.1016/j.addr.2012.10.00210.1016/j.addr.2012.10.002 ↗
33. 10.1038/nphoton.2013.27210.1038/nphoton.2013.272 ↗
34. 10.1039/b900654k10.1039/b900654k ↗
35. 10.1016/j.ijheatmasstransfer.2004.09.01610.1016/j.ijheatmasstransfer.2004.09.016 ↗
36. 10.1021/cm504406a10.1021/cm504406a ↗
37. 10.1039/C8NR00413G10.1039/C8NR00413G ↗
38. 10.1021/jp408249q10.1021/jp408249q ↗
39. 10.1021/jp307573c10.1021/jp307573c ↗
40. 10.1038/ncomms969610.1038/ncomms9696 ↗
41. 10.1002/adma.20160479710.1002/adma.201604797 ↗
42. 10.1038/ncomms880010.1038/ncomms8800 ↗
43. 10.1016/j.isci.2018.11.01710.1016/j.isci.2018.11.017 ↗
44. 10.1021/ja808277u10.1021/ja808277u ↗
45. 10.1021/jz500037k10.1021/jz500037k ↗
46. 10.1021/am201455x10.1021/am201455x ↗
47. 10.1021/jp502067510.1021/jp5020675 ↗
48. 10.1063/1.363415010.1063/1.3634150 ↗
49. 10.1039/C8CP00014J10.1039/C8CP00014J ↗
50. 10.1021/ja205787410.1021/ja2057874 ↗
51. 10.1038/nmat369710.1038/nmat3697 ↗
52. 10.1038/ncomms688110.1038/ncomms6881 ↗
53. 10.1021/acs.analchem.6b0291710.1021/acs.analchem.6b02917 ↗
54. 10.1039/C4AN00371C10.1039/C4AN00371C ↗
55. 10.1166/jnn.2013.691710.1166/jnn.2013.6917 ↗
56. 10.1038/cddis.2013.7610.1038/cddis.2013.76 ↗
57. 10.1016/j.nano.2008.04.00110.1016/j.nano.2008.04.001 ↗
58. 10.1186/s12645-019-0052-110.1186/s12645-019-0052-1 ↗
59. 10.2217/17435889.3.1.8310.2217/17435889.3.1.83 ↗
60. 10.1002/ijc.1150010.1002/ijc.11500 ↗
61. 10.1021/jp076293110.1021/jp0762931 ↗
62. 10.1097/MPA.0b013e31815a3f1c10.1097/MPA.0b013e31815a3f1c ↗
63. 10.1038/nrc188510.1038/nrc1885 ↗
64. 10.1111/j.1365-2559.2010.03681.x10.1111/j.1365-2559.2010.03681.x ↗
65. 10.1007/s10555-014-9511-710.1007/s10555-014-9511-7 ↗
66. 10.1158/0008-5472.CAN-11-234510.1158/0008-5472.CAN-11-2345 ↗
67. 10.1039/C4AN01875C10.1039/C4AN01875C ↗